The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription
Open accessAbstract
Maintaining muscle size and fiber composition requires contractile activity. Increased activity stimulates expression of the transcriptional coactivator PGC-1α (peroxisome proliferator-activated receptor γ coactivator 1α), which promotes fiber-type switching from glycolytic toward more oxidative fibers. In response to disuse or denervation, but also in fasting and many systemic diseases, muscles undergo marked atrophy through a common set of transcriptional changes. FoxO family transcription factors play a critical role in this loss of cell protein, and when activated, FoxO3 causes expression of the atrophy-related ubiquitin ligases atrogin-1 and MuRF-1 and profound loss of muscle mass. To understand how exercise might retard muscle atrophy, we investigated the possible interplay between PGC-1α and the FoxO family in regulation of muscle size. Rodent muscles showed a large decrease in PGC-1α mRNA during atrophy induced by denervation as well as by cancer cachexia, diabetes, and renal failure. Furthermore, in transgenic mice overexpressing PGC-1α, denervation and fasting caused a much smaller decrease in muscle fiber diameter and a smaller induction of atrogin-1 and MuRF-1 than in control mice. Increased expression of PGC-1α also increased mRNA for several genes involved in energy metabolism whose expression decreases during atrophy. Transfection of PGC-1α into adult fibers reduced the capacity of FoxO3 to cause fiber atrophy and to bind to and transcribe from the atrogin-1 promoter. Thus, the high levels of PGC-1α in dark and exercising muscles can explain their resistance to atrophy, and the rapid fall in PGC-1α during atrophy should enhance the FoxO-dependent loss of muscle mass.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PPARGC1A, the gene that encodes PGC‐1α, is most well‐known for its role in mitochondrial biogenesis but has been reported to protect muscle mass in the context of muscle atrophy triggered by aging (Yang et al., 2020), chronic heart failure, and various other muscle wasting conditions (Sandri et al., 2006).”
From Autophagy gene expression in skeletal muscle of older individuals is associated with physical performance, muscle volume and mitochondrial function in the study of muscle, mobility and aging ( SOMMA ) (2024) · cites this paper as Sandri et al., 2006
Experimental — accuracy not yet measuredIn the citing paper
“PGC-1α is a transcriptional coactivator that has reduced gene expression in muscles of patients with type 2 diabetes,55 and might have a role in preventing muscle atrophy.53,56”
From Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases (2014) · cites this paper as [53]
In the citing paper
“Myofibre size in skeletal muscle is also reduced in people with type 2 diabetes.53”
From Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases (2014) · cites this paper as [53]
In the citing paper
“First, skeletal muscles are heterogeneous with respect to fiber type and metabolic properties and therefore they vary, often drastically, in their response to the same stimulus.”
From Mechanisms of muscle atrophy and hypertrophy: implications in health and disease (2021) · cites this paper as [2]
In the citing paper
“For instance, slow muscles, such as the soleus, are less sensitive to starvation compared to fast muscles2, while during disuse such as that induced by hind limb suspension, the soleus atrophies faster than glycolytic (fast) muscles3.”
From Mechanisms of muscle atrophy and hypertrophy: implications in health and disease (2021) · cites this paper as [2]
In the citing paper
“For instance, JunB, PGC1α, and PGC1β all inhibit FoxO activity in skeletal muscles2,67,68, while the glucocorticoid receptor and β−catenin synergize with FoxOs to promote muscle wasting69.”
From Mechanisms of muscle atrophy and hypertrophy: implications in health and disease (2021) · cites this paper as [2]
In the citing paper
“With aging, PGC-1α levels dramatically fall in the skeletal muscle [86], while the maintenance of PGC-1α expression preserves muscle mass during sarcopenia, cachexia, denervation, and fasting [85,87].”
From Role of Age-Related Mitochondrial Dysfunction in Sarcopenia (2020) · cites this paper as [85]
In the citing paper
“This phenomenon seems to be mediated by the promotion of mitochondrial turnover and quality control [85,87].”
From Role of Age-Related Mitochondrial Dysfunction in Sarcopenia (2020) · cites this paper as [85]
In the citing paper
“PGC-1α may also prevent muscle atrophy through the regulation of autophagy [85].”
From Role of Age-Related Mitochondrial Dysfunction in Sarcopenia (2020) · cites this paper as [85]
In the citing paper
“Because exercise and ApN share similar signaling pathways [75,76] and the potential of counteracting several facets of this metabolic syndrome, numerous studies attempted to establish relationships between exercise and ApN parameters.”
From Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together? (2020) · cites this paper as [75]
In the citing paper
“The transcriptional activity of FoxO3 is inhibited, on one hand, by PGC-1α and on the other hand, by the insulin/IGF1 signaling pathway, which also activates protein synthesis [75].”
From Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together? (2020) · cites this paper as [75]
In the citing paper
“Forkhead box O (FoxO) family TF play a critical role in protein breakdown by activating the expression of atrogenes (which include two muscle-specific ubiquitin ligases, atrogin-1 and MuRF1) responsible for profound loss of muscle mass [75].”
From Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together? (2020) · cites this paper as [75]
In the citing paper
“PGC-1α reduces muscle protein degradation by the UPS via blocking nuclear factor κB (NF-κB) and FoxO3 activity (16, 124).”
From Mitochondria initiate and regulate sarcopenia (2017) · cites this paper as [124]
In the citing paper
“Thus, high-level expression of PGC-1 may actually cause accumulation of lipids and/or incomplete oxidation products, leading to reduced insulin sensitivity, as observed in PGC-1␣ transgenic mice (267-269).”
From The role of mitochondria in the pathogenesis of type 2 diabetes (2010) · cites this paper as [269]
In the citing paper
“When PGC-1␣ overexpression is restricted to skeletal muscle but overexpressed throughout development by the use of the creatine kinase gene promoter, very large increases in mitochondrial mass, OXPHOS, and fatty acid oxidation genes are observed (267-269).”
From The role of mitochondria in the pathogenesis of type 2 diabetes (2010) · cites this paper as [269]
In the citing paper
“Despite these effects, insulin sensitivity is normal in PGC-1␣ transgenic mice fed a chow diet and, surprisingly, is reduced during high-fat feeding.”
From The role of mitochondria in the pathogenesis of type 2 diabetes (2010) · cites this paper as [269]
In the citing paper
“In this model, ATP synthesis rate and exercise performance are increased, and fatty acid oxidation is also enhanced.”
From The role of mitochondria in the pathogenesis of type 2 diabetes (2010) · cites this paper as [269]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium's Role in Mechanotransduction during Muscle Development
Damm, T. B., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,552
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
Self-citationA Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Self-citationIdentification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Self-citationTranscriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546
Self-citationMetabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130
Self-citationStitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., & Goldberg, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251541198 · Cited by 1,774
Self-citationMultiple types of skeletal muscle atrophy involve a common program of changes in gene expression
Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S. R., Mitch, W. E., & Goldberg, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0610com · Cited by 1,539
Self-citation
Flagged first, then by citations
Research works printed but not linked: 7
- JM Sacheck, J-P Hyatt, A Raffaello, RT Jagoe, RR Roy, VR Edgerton, SH Lecker, AL Goldberg FASEB J, in press. (2006).
- G Tiao, M Lieberman, JE Fischer, PO Hasselgren Am J Physiol 272, R849–R856 (1997).
- VE Baracos, C DeVivo, DH Hoyle, AL Goldberg Am J Physiol 268, E996–E1006 (1995).
- 10.1172/JCI200420174 · DOI
- GJ Herbison, MM Jaweed, JF Ditunno Arch Phys Med Rehab 60, 401–404 (1979).
- IC Kettelhut, MT Pepato, RH Migliorini, R Medina, AL Goldberg Braz J Med Biol Res 27, 981–993 (1994).
- SS Wing, AL Goldberg Am J Physiol 264, E668–E676 (1993).
Cited by
Sorted by citations
Items 201–300 of 973
Yu, Y., Zhao, Y., Teng, F., Li, J., Guan, Y., Xu, J., Lv, X., Guan, F., Zhang, M., & Chen, L. (2018) · The journal of nutrition health & aging · doi:10.1007/s12603-018-1015-7 · Cited by 111
Wang, L., Jiao, X.-F., Wu, C., Li, X., Sun, H., Shen, X.-Y., Zhang, K., Zhao, C., Liu, L., Wang, M., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00648-0 · Cited by 114
Koutakis, P., Weiss, D. J., Miserlis, D., Shostrom, V., Papoutsi, E., Ha, D. M., Carpenter, L. A., McComb, R. D., Casale, G. P., & Pipinos, I. I. (2014) · Redox Biology · doi:10.1016/j.redox.2014.07.002 · Cited by 108
The biology of PGC-1α and its therapeutic potential
Handschin, C. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.03.006 · Cited by 108
Self-citationKavazis, A. N., Smuder, A. J., & Powers, S. K. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00210.2014 · Cited by 114
Oxidative stress: an evolving definition
Ji, L. L., & Yeo, D. (2021) · Faculty Reviews · doi:10.12703/r/10-13 · Cited by 121
Skeletal muscle dysfunction in critical care: Wasting, weakness, and rehabilitation strategies
Puthucheary, Z., Harridge, S. D. R., & Hart, N. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181f2458d · Cited by 108
Smad3 signaling is required for satellite cell function and myogenic differentiation of myoblasts
Ge, X., McFarlane, C., Vajjala, A., Lokireddy, S., Zhi Hui Melissa, N. G., Tan, C. K., Tan, N. S., Wahli, W., Sharma, M., & Kambadur, R. (2011) · Cell Research · doi:10.1038/cr.2011.72 · Cited by 107
Tian, Z., Cui, Y., Lu, H., Wang, G., & Ma, X. (2020) · Meat Science · doi:10.1016/j.meatsci.2020.108234 · Cited by 109
Muscle atrophy in experimental cancer cachexia: Is the IGF‐1 signaling pathway involved?
Penna, F., Bonetto, A., Muscaritoli, M., Costamagna, D., Minero, V. G., Bonelli, G., Fanelli, F. R., Baccino, F. M., & Costelli, P. (2009) · International Journal of Cancer · doi:10.1002/ijc.25146 · Cited by 109
de Souza, R. W. A., Piedade, W. P., Soares, L. C., Castro, P. A. T. D. S., Aguiar, A. F., Vechetti, I. J., de Campos, D. H. S., Fernandes, A. A. H., Okoshi, K., Carvalho, R. F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110020 · Cited by 104
Ubiquitin-proteasome pathway in skeletal muscle atrophy
Pang, X., Zhang, P., Chen, X., & Liu, W. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1289537 · Cited by 120
Myogenin regulates denervation-dependent muscle atrophy in mouse soleus muscle
Macpherson, P. C. D., Wang, X., & Goldman, D. J. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23136 · Cited by 107
Fang, C. X., Dong, F., Thomas, D. P., Ma, H., He, L., & Ren, J. T. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00319.2008 · Cited by 108
Life-long spontaneous exercise does not prolong lifespan but improves health span in mice
Garcia-Valles, R., Gómez‐Cabrera, M. C., Rodríguez‐Mañas, L., García‐García, F. J., Díaz, A., Noguera, I., González, G. O., & Viña, J. (2013) · Longevity & Healthspan · doi:10.1186/2046-2395-2-14 · Cited by 107
Structure to function: muscle failure in critically ill patients
Puthucheary, Z., Montgomery, H., Moxham, J., Harridge, S. D. R., & Hart, N. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.197632 · Cited by 106
Minireview: The PGC-1 Coactivator Networks: Chromatin-Remodeling and Mitochondrial Energy Metabolism
Lin, J. D. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0344 · Cited by 103
Self-citationCarson, J. A., Hardee, J. P., & VanderVeen, B. N. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.11.005 · Cited by 109
Factors mediating spaceflight-induced skeletal muscle atrophy
Lee, P. H. U., Chung, M., Ren, Z., Mair, D. B., & Kim, D. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00203.2021 · Cited by 104
The role of PGC‐1 coactivators in aging skeletal muscle and heart
Dillon, L. M., Rebelo, A. P., & Moraes, C. T. (2012) · IUBMB Life · doi:10.1002/iub.608 · Cited by 116
Prmt7 Deficiency Causes Reduced Skeletal Muscle Oxidative Metabolism and Age-Related Obesity
Jeong, H.-J., Lee, H.-J., Vuong, T. A., Choi, K.-S., Choi, D., Koo, S.-H., Cho, S. C., Cho, H., & Kang, J.-S. (2016) · Diabetes · doi:10.2337/db15-1500 · Cited by 101
miR-182 attenuates atrophy-related gene expression by targeting FoxO3 in skeletal muscle
Hudson, M. B., Rahnert, J. A., Zheng, B., Woodworth‐Hobbs, M. E., Franch, H. A., & Price, S. R. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00395.2013 · Cited by 101
Role of PGC-1α in Vascular Regulation
Kadlec, A. O., Chabowski, D. S., Ait‐Aissa, K., & Gutterman, D. D. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307123 · Cited by 103
Zhang, L., Xin, C., Wang, S., Zhuo, S., Zhu, J., Li, Z., Liu, Y., Yang, L., & Chen, Y. (2024) · Science Advances · doi:10.1126/sciadv.adn4508 · Cited by 103
Hafen, P. S., Abbott, K., Bowden, J. A., Lopiano, R., Hancock, C. R., & Hyldahl, R. D. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01098.2018 · Cited by 108
Kang, S., Lee, H., Kim, M. K., Lee, E., Sohn, U. D., & Kim, I. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00389.2016 · Cited by 100
Chopard, A., Hillock, S., & Jasmin, B. J. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00864.x · Cited by 106
Increased mitochondrial biogenesis in muscle improves aging phenotypes in the mtDNA mutator mouse
Dillon, L. M., Williams, S. L., Hida, A., Peacock, J. D., Prolla, T. A., Lincoln, J., & Moraes, C. T. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds049 · Cited by 102
p38 MAPK in Glucose Metabolism of Skeletal Muscle: Beneficial or Harmful?
Bengal, E., Aviram, S., & Hayek, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186480 · Cited by 102
Skeletal muscle dysfunction in COPD: clinical and laboratory observations
Man, W. D., Kemp, P. R., Moxham, J., & Polkey, M. I. (2009) · Clinical Science · doi:10.1042/cs20080659 · Cited by 101
Skeletal muscle mitochondrial uncoupling in a murine cancer cachexia model
Tzika, A. A., de Oliveira, C. C. F., Shestov, A. A., Constantinou, C., Psychogios, N., Righi, V., Mintzopoulos, D., Busquets, S., López-Soriano, F. J., Milot, S. M., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1998 · Cited by 96
Recent advances in understanding the role of FOXO3
Stefanetti, R. J., Voisin, S. A. C., Russell, A. P., & Lamon, S. (2018) · F1000Research · doi:10.12688/f1000research.15258.1 · Cited by 95
Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations
Pin, F., Busquets, S., Toledo, M., Camperi, A., López-Soriano, F. J., Costelli, P., Argilés, J. M. A., & Penna, F. (2015) · Oncotarget · doi:10.18632/oncotarget.6439 · Cited by 101
Moriggi, M., Vasso, M., Fania, C., Capitanio, D., Bonifacio, G. J., Michele Salanova, A., Blottner, D., Rittweger, J., Felsenberg, D., Cerretelli, P., et al. (2010) · PROTEOMICS · doi:10.1002/pmic.200900817 · Cited by 96
Statins, Muscle Disease and Mitochondria
Ramachandran, R., & Wierzbicki, A. S. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6080075 · Cited by 91
Brocca, L., Toniolo, L., Reggiani, C., Bottinelli, R., Sandri, M., & Pellegrino, M. A. (2017) · The Journal of Physiology · doi:10.1113/jp273097 · Cited by 93
Self-citationMitochondrial PE potentiates respiratory enzymes to amplify skeletal muscle aerobic capacity
Heden, T. D., Johnson, J. M., Ferrara, P. J., Eshima, H., Verkerke, A. R. P., Wentzler, E. J., Siripoksup, P., Narowski, T. M., Coleman, C. B., Lin, C., et al. (2019) · Science Advances · doi:10.1126/sciadv.aax8352 · Cited by 91
Kang, C., Goodman, C. A., Hornberger, T. A., & Ji, L. L. (2015) · The FASEB Journal · doi:10.1096/fj.14-266619 · Cited by 99
HDAC4 Controls Muscle Homeostasis through Deacetylation of Myosin Heavy Chain, PGC-1α, and Hsc70
Luo, L., Martin, S. C., Parkington, J. D., Cadena, S. M., Zhu, J., Ibebunjo, C., Summermatter, S., Londraville, N., Patora‐Komisarska, K., Widler, L., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.023 · Cited by 93
Marceca, G. P., Londhe, P., & Calore, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00298 · Cited by 92
Benton, C. R., Wright, D. C., & Bonen, A. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-074 · Cited by 95
PGC‐1α activation as a therapeutic approach in mitochondrial disease
Wenz, T. (2009) · IUBMB Life · doi:10.1002/iub.261 · Cited by 91
Vainshtein, A., Grumati, P., Sandri, M., & Bonaldo, P. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1096-z · Cited by 88
Self-citationSmith, I. J., Alamdari, N., O’Neal, P., GONNELLA, P. A., Aversa, Z., & Hasselgren, P.-O. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.01.006 · Cited by 88
Geng, T., Li, P., Yin, X., & Yan, Z. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.005 · Cited by 90
Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks
Wing, S. S., Lecker, S. H., & Jagoe, R. T. (2011) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2011.586171 · Cited by 93
Self-citationMetabolic remodeling agents show beneficial effects in the dystrophin- deficient mdx mouse model
Jahnke, V. E., van der Meulen, J. H., Johnston, H., Ghimbovschi, S. D., Partridge, T., Hoffman, E. P., & Nagaraju, K. (2012) · Skeletal Muscle · doi:10.1186/2044-5040-2-16 · Cited by 92
Shrikrishna, D., Astin, R., Kemp, P. R., & Hopkinson, N. S. (2012) · Clinical Science · doi:10.1042/cs20120081 · Cited by 92
Mitochondrial Dysfunction in Skeletal Muscle Pathologies
Abrigo, J., Simon, F., Cabrera, D., Vilos, C., & Cabello-Verrugio, C. (2019) · Current Protein & Peptide Science · doi:10.2174/1389203720666190402100902 · Cited by 88
Molecular and neuroendocrine mechanisms of cancer cachexia
Mendes, M. C. S., Pimentel, G. D., Costa, F. O., & Carvalheira, J. B. C. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0170 · Cited by 89
AMPK inhibits myoblast differentiation through a PGC-1α-dependent mechanism
Williamson, D. L., Butler, D. C., & Alway, S. E. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.91007.2008 · Cited by 91
Jung, H. W., Kang, A. N., Kang, S., Park, Y., & Song, M. (2017) · Nutrients · doi:10.3390/nu9010033 · Cited by 88
Mitochondrial dysregulation and muscle disuse atrophy
Ji, L. L., & Yeo, D. (2019) · F1000Research · doi:10.12688/f1000research.19139.1 · Cited by 88
Penna, F., Busquets, S., Pin, F., Toledo, M., Baccino, F. M., López-Soriano, F. J., Costelli, P., & Argilés, J. M. A. (2011) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-011-0028-4 · Cited by 86
Activity level, apoptosis, and development of cachexia in Apc Min /+ mice
Baltgalvis, K. A., Berger, F. G., Peña, M. M. O., Davis, J. M., White, J. P., & Carson, J. A. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00442.2010 · Cited by 84
Pgc-1α overexpression Via local transfection attenuates mitophagy pathway in muscle disuse atrophy
Kang, C., & Ji, L. L. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.032 · Cited by 83
Intercellular: local and systemic actions of skeletal muscle PGC-1s
Correia, J. C., Ferreira, D. M. S., & Ruas, J. L. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.03.010 · Cited by 84
A Fork in the Path: Developing Therapeutic Inroads with FoxO Proteins
Maiese, K., Hou, J., Chong, Z. Z., & Shang, Y. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.3.8916 · Cited by 82
Protective Effects of Ghrelin on Fasting-Induced Muscle Atrophy in Aging Mice
Wu, C.-S., Wei, Q., Wang, H., Kim, D. M., Balderas, M., Wu, G., Lawler, J., Safe, S., Guo, S., Devaraj, S., et al. (2020) · The Journals of Gerontology: Series A · doi:10.1093/gerona/gly256 · Cited by 81
Dantas, W. S., Zunica, E. R. M., Heintz, E. C., Vandanmagsar, B., Floyd, Z. E., Yu, Y., Fujioka, H., Hoppel, C. L., Belmont, K. P., Axelrod, C. L., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12982 · Cited by 84
β2-Adrenergic agonists and the treatment of skeletal muscle wasting disorders
Joassard, O. R., Durieux, A., & Freyssenet, D. G. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.06.025 · Cited by 85
Muscle Fiber Type-Dependent Differences in the Regulation of Protein Synthesis
Goodman, C. A., Kotecki, J. A., Jacobs, B. L., & Hornberger, T. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037890 · Cited by 82
Arany, Z. P., Wagner, B. K., Ma, Y., Chinsomboon, J., Laznik, D., & Spiegelman, B. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800979105 · Cited by 81
Self-citationMolecular regulation of skeletal muscle mass
Russell, A. P. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05265.x · Cited by 80
Meyer, A., Zoll, J., Charles, A. L., Charloux, A., de Blay, F., Diemunsch, P., Sibilia, J., Piquard, F., & Geny, B. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2012.069468 · Cited by 90
Menshikova, E. V., Ritov, V. B., Dube, J. J., Amati, F., Stefanovic-Racic, M., Toledo, F. G. S., Coen, P. M., & Goodpaster, B. H. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw328 · Cited by 80
Iolascon, G. (2014) · Clinical cases in mineral and bone metabolism · doi:10.11138/ccmbm/2014.11.3.215 · Cited by 80
Chen, W., Zhang, X., Birsoy, K., & Roeder, R. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005626107 · Cited by 79
Tamura, Y., Kitaoka, Y., Matsunaga, Y., Hoshino, D., & Hatta, H. (2015) · The Journal of Physiology · doi:10.1113/jp270093 · Cited by 83
Muscle immobilization activates mitophagy and disrupts mitochondrial dynamics in mice
Kang, C., Yeo, D., & Ji, L. L. (2016) · Acta Physiologica · doi:10.1111/apha.12690 · Cited by 81
Dkk3 dependent transcriptional regulation controls age related skeletal muscle atrophy
Yin, J., Yang, L., Xie, Y., Liu, Y., Li, S., Yang, W., Xu, B., Ji, H., Ding, L., Wang, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04038-6 · Cited by 72
Self-citationGCN5 acetyltransferase in cellular energetic and metabolic processes
Mutlu, B., & Puigserver, P. (2020) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2020.194626 · Cited by 82
The “irisin system”: From biological roles to pharmacological and nutraceutical perspectives
Flori, L., Testai, L., & Calderone, V. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118954 · Cited by 81
Mitochondrial Dysfunction in Cancer Cachexia: Impact on Muscle Health and Regeneration
Beltrà, M., Pin, F., Ballarò, R., Costelli, P., & Penna, F. (2021) · Cells · doi:10.3390/cells10113150 · Cited by 78
Mukai, R., Matsui, N., Fujikura, Y., Matsumoto, N., Hou, D., Kanzaki, N., Shibata, H., Horikawa, M., Iwasa, K., Hirasaka, K., et al. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.02.001 · Cited by 76
Seiler, M., Bowen, T. S., Rolim, N. P. L., Dieterlen, M., Werner, S., Hoshi, T., Fischer, T., Mangner, N., Linke, A. H.-P., Schuler, G. C., et al. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.116.003027 · Cited by 75
Martı́n, A. I., Priego, T., & López‐Calderón, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_9 · Cited by 84
Trevino, M. B., Zhang, X., Standley, R. A., Wang, M., Han, X., Reis, F. C. G., Periasamy, M., Yu, G., Kelly, D. P., Goodpaster, B. H., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00161.2019 · Cited by 73
Vermillion, K. L., Anderson, K. J., Hampton, M. E., & Andrews, M. T. (2015) · Physiological Genomics · doi:10.1152/physiolgenomics.00108.2014 · Cited by 77
Emerging role of neuregulin as a modulator of muscle metabolism
Gumà, A., Martínez-Redondo, V., López‐Soldado, I., Cantó, C., & Antonio Zorzano, A. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00541.2009 · Cited by 77
TWEAK/Fn14 Signaling Axis Mediates Skeletal Muscle Atrophy and Metabolic Dysfunction
Sato, S., Ogura, Y., & Kumar, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00018 · Cited by 74
Abou-Samra, M., Selvais, C. M., Dubuisson, N., & Brichard, S. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072620 · Cited by 72
Kang, C., & Ji, L. L. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01354.2012 · Cited by 74
Khan, M. P., Singh, A. K., Joharapurkar, A. A., Yadav, M., Shree, S., Kumar, H., Gurjar, A. A., Mishra, J. S., Tiwari, M. C., Nagar, G. K., et al. (2015) · Diabetes · doi:10.2337/db14-1611 · Cited by 73
Crupi, A. N., Nunnelee, J. S., Taylor, D. J., Thomas, A., Vit, J., Riera, C. E., Gottlieb, R. A., & Goodridge, H. S. (2018) · Aging · doi:10.18632/aging.101643 · Cited by 72
Lippi, L., de Sire, A., Mezian, K., Curci, C., Perrero, L., Turco, A., Andaloro, S., Ammendolia, A., Fusco, N., & Invernizzi, M. (2022) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-02073-w · Cited by 65
Bonen, A. (2009) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h09-008 · Cited by 70
Fuentes, E. N., Safian, D., Einarsdottir, I. E., Valdés, J. A., Elorza, Á. A., Molina, A., & Björnsson, B. T. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.02.009 · Cited by 72
Gill, J. F., Santos, G., Schnyder, S., & Handschin, C. (2018) · Aging Cell · doi:10.1111/acel.12697 · Cited by 72
Self-citationFebbraio, M. A. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00414.2007 · Cited by 70
Mittenbühler, M. J., Jedrychowski, M. P., Vranken, J. G. V., Sprenger, H., Wilensky, S. E., Dumesic, P. A., Sun, Y., Tartaglia, A., Laznik-Bogoslavski, D., Mu, A., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.12.014 · Cited by 68
Self-citationCobley, J. N., Moult, P. R., Burniston, J. G., Morton, J. P., & Close, G. L. (2014) · Biogerontology · doi:10.1007/s10522-014-9546-8 · Cited by 74
Conte, E., Camerino, G. M., Mele, A., Bellis, M. D., Pierno, S., Rana, F., Fonzino, A., Caloiero, R., Rizzi, L., Bresciani, E., et al. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12185 · Cited by 71
Cancer-Mediated Muscle Cachexia: Etiology and Clinical Management
Siff, T. E., Parajuli, P., Razzaque, M. S., & Atfi, A. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.03.007 · Cited by 73
Research progress on Sirtuins (SIRTs) family modulators
Chen, M., Tan, J., Jin, Z., Jiang, T., Wu, J., & Yu, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116481 · Cited by 73
Regulatory circuitry of TWEAK‐Fn14 system and PGC‐1α in skeletal muscle atrophy program
Hindi, S. M., Mishra, V. K., Bhatnagar, S., Tajrishi, M. M., Ogura, Y., Yan, Z., Burkly, L. C., Zheng, T. S., & Kumar, A. (2013) · The FASEB Journal · doi:10.1096/fj.13-242123 · Cited by 69
Kupr, B., & Handschin, C. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00325 · Cited by 69
Self-citationDHPR α1S subunit controls skeletal muscle mass and morphogenesis
Piétri‐Rouxel, F., Gentil, C., Vassilopoulos, S., Baas, D., Mouisel, É., Ferry, A., Vignaud, A., Hourdé, C., Marty, I., Schaeffer, L., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.366 · Cited by 68
Mitochondrial biogenesis and fragmentation as regulators of protein degradation in striated muscles
Romanello, V., & Sandri, M. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.08.001 · Cited by 70
Self-citationThe TWEAK-Fn14 Pathway: A Potent Regulator of Skeletal Muscle Biology in Health and Disease
Tajrishi, M. M., Zheng, T. S., Burkly, L., & Kumar, A. (2013) · Cytokine & growth factor reviews · doi:10.1016/j.cytogfr.2013.12.004 · Cited by 60
Metadata
- Authors
- Sandri, M., Lin, J., Handschin, C., Yang, W., Arany, Z. P., Lecker, S. H., Goldberg, A. L., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- Beth Israel Deaconess Medical Center (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-10-31
- Volume
- 103
- Issue
- 44
- Pages
- 16260-16265
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1637570
- OpenAlex
- W1977548231
- Cited by
- 974
- References
- 53
- Citations by year
- 2026: 20 · 2025: 38 · 2024: 44 · 2023: 51 · 2022: 56 · 2021: 42 · 2020: 66 · 2019: 64 · 2018: 54 · 2017: 40 · 2016: 51 · 2015: 57 · 2014: 65 · 2013: 68 · 2012: 52
- FWCI
- 13.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- edoc (University of Basel) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- edoc (University of Basel)
- Funders
- Muscular Dystrophy Association
- Compagnia di San Paolo
- National Institutes of Health (DK6230701)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-6230701, R01DK062307, R56DK054477, P30DK040561)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- PGC-1α, skeletal muscle atrophy, FOXO3, atrogin-1, MuRF1, ubiquitin ligase, denervation, cancer cachexia, diabetes mellitus, renal failure, fasting, physical activity, muscle fiber diameter, energy metabolism, transcriptional coactivator, muscle fiber type shift
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Gene Expression Regulation, Mice, Transgenic, Muscular Atrophy, Nerve Tissue Proteins, Transcription Factors, Transcription, Genetic, Biomarkers, Trans-Activators, Muscle, Skeletal, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
